Healthcare -
Biotechnology - NASDAQ - US
$ 0.6154
-1.92 %
$ 56.9 M
Market Cap
-0.51
P/E
VRCA - COST OF REVENUE
Cost of Revenue VRCA - Verrica Pharmaceuticals Inc.
1.85 M
LAST VALUE
59.87%
2 YEAR CAGR
48.43%
5 YEAR CAGR
0.00%
10 YEAR CAGR